Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
e-Letters: Comments and Responses

Comment on Law et al. Suboptimal Nocturnal Glucose Control Is Associated With Large for Gestational Age in Treated Gestational Diabetes Mellitus. Diabetes Care 2019;42:810–815

  1. Ninon Foussard⇑,
  2. Sophie Cambos,
  3. Pauline Poupon,
  4. Marie Monlun,
  5. Laurence Blanco,
  6. Magalie Haissaguerre,
  7. Virginie Grouthier,
  8. Fritz-Line Velayoudom-Cephise,
  9. Kamel Mohammedi and
  10. Vincent Rigalleau
  1. Endocrinology-Nutrition Department, Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
  1. Corresponding author: Ninon Foussard, ninonfoussard{at}yahoo.fr
Diabetes Care 2019 Jul; 42(7): e122-e122. https://doi.org/10.2337/dc19-0446
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

We were interested in the article by Law et al. (1), who reported that high nocturnal glucose, as recorded by continuous glucose monitoring (CGM), was associated with large for gestational age (LGA) newborns in women with gestational diabetes mellitus (GDM). The nocturnal hyperglycemia was not detected by fasting self-monitored blood glucose (SMBG), which argues for performing CGM in GDM.

The figure in the article nicely depicts how nocturnal hyperglycemia was missed by conventional SMBG: as underlined by the authors, the difference in nocturnal CGM glucose between mothers of LGA infants and those of normal-weight newborns was a peak displayed at 0200–0300 h, which then progressively declined to become nonsignificant when the women woke up. This 0200–0300 h glucose peak seems to be an important finding. For patients with type 1 or type 2 diabetes, CGM usually detects numerous hypoglycemias during this time interval (2), but this pattern may change at the end of pregnancy, when insulin resistance progresses. Accordingly, in a previous study that included pregnant women with type 1 or type 2 diabetes, Law et al. (3) reported declining nocturnal CGM glucose (nadir at 0400 h) in the first trimester of pregnancy and peaking nocturnal glucose in the second and third trimesters. They hypothesized that nocturnal hyperglycemia may result from diet, sedentary behavior, difficulty sleeping, or increased endogenous glucose production.

Whatever the mechanism, a nocturnal hyperglycemia peak in mothers of LGA infants has implications for the choice of second-line therapies. When SMBG targets were not reached by their patients through dietary and lifestyle advice, Law et al. (1) used metformin, which may help to reduce nocturnal endogenous glucose production, and/or insulin, but they did not report which long-acting insulins were injected in the evening.

Euglycemic clamp studies have shown that NPH insulin, in contrast to insulin glargine, has an action peak 4 h after injection (4), which may help to reduce the 0200–0300 h glucose as reported by CGM data in type 2 diabetes (5) and to reduce the risk of hypoglycemia later, when CGM glucose declined in mothers of LGA infants. To our knowledge, there is no concern about the safety of using glargine in women with GDM, but the peaking nocturnal glucose profiles as reported by Law et al. (1) argue for the injection of insulin NPH in the late evening if the aim is to correct the nocturnal hyperglycemia that may drive fetal growth acceleration.

The women who participated in the study by Law et al. (1) had a diagnosis of GDM at ∼26 weeks’ gestation, and the CGM was performed at 30–32 weeks’ gestation. We can speculate that some of them were then still on first-line therapy and had to start second-line therapy based on SMBG results after their CGM glucose had been recorded. If women who later started evening insulin NPH or metformin had nocturnal high CGM glucose, this would argue for the use of these recommended therapies to correct the nocturnal high glucose. If not, this would argue for performing CGM before introducing an appropriate second-line treatment to better address nocturnal glucose control.

Article Information

Duality of Interest. No potential conflicts of interest relevant to this article were reported.

  • © 2019 by the American Diabetes Association.
http://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

References

  1. ↵
    1. Law GR,
    2. Alnaji A,
    3. Alrefaii L, et al
    . Suboptimal nocturnal glucose control is associated with large for gestational age in treated gestational diabetes mellitus. Diabetes Care 2019;42:810–815
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Bode BW,
    2. Schwartz S,
    3. Stubbs HA,
    4. Block JE
    . Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values. Diabetes Care 2005;28:2361–2366
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Law GR,
    2. Ellison GTH,
    3. Secher AL, et al
    . Analysis of continuous glucose monitoring in pregnant women with diabetes: distinct temporal patterns of glucose associated with large-for-gestational-age infants. Diabetes Care 2015;38:1319–1325
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Heinemann L,
    2. Linkeschova R,
    3. Rave K,
    4. Hompesch B,
    5. Sedlak M,
    6. Heise T
    . Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care 2000;23:644–649
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Wang XL,
    2. Lu JM,
    3. Pan CY, et al
    . Evaluation of the superiority of insulin glargine as basal insulin replacement by continuous glucose monitoring system. Diabetes Res Clin Pract 2007;76:30–36
    OpenUrlCrossRefPubMed
PreviousNext
Back to top
Diabetes Care: 42 (7)

In this Issue

July 2019, 42(7)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comment on Law et al. Suboptimal Nocturnal Glucose Control Is Associated With Large for Gestational Age in Treated Gestational Diabetes Mellitus. Diabetes Care 2019;42:810–815
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Comment on Law et al. Suboptimal Nocturnal Glucose Control Is Associated With Large for Gestational Age in Treated Gestational Diabetes Mellitus. Diabetes Care 2019;42:810–815
Ninon Foussard, Sophie Cambos, Pauline Poupon, Marie Monlun, Laurence Blanco, Magalie Haissaguerre, Virginie Grouthier, Fritz-Line Velayoudom-Cephise, Kamel Mohammedi, Vincent Rigalleau
Diabetes Care Jul 2019, 42 (7) e122; DOI: 10.2337/dc19-0446

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Comment on Law et al. Suboptimal Nocturnal Glucose Control Is Associated With Large for Gestational Age in Treated Gestational Diabetes Mellitus. Diabetes Care 2019;42:810–815
Ninon Foussard, Sophie Cambos, Pauline Poupon, Marie Monlun, Laurence Blanco, Magalie Haissaguerre, Virginie Grouthier, Fritz-Line Velayoudom-Cephise, Kamel Mohammedi, Vincent Rigalleau
Diabetes Care Jul 2019, 42 (7) e122; DOI: 10.2337/dc19-0446
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Article Information
    • References
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Response to Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128–2136
  • Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128–2136
  • Comment on Gan et al. Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2020;43:1948–1957
Show more e-Letters: Comments and Responses

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.